Apoptotic Donor Cells in Transplantation.

Area of Science:

• Immunology
• Transplantation Biology
• Cell Therapy

Background:

• Current immunosuppressive therapies for organ transplantation face challenges including long-term graft survival, side effects, and opportunistic infections.
• Existing methods for inducing transplantation tolerance, such as hematopoietic chimerism, carry risks like graft-versus-host disease and uncertain tolerance persistence.

Purpose of the Study:

• To review laboratory and clinical evidence supporting apoptotic cell-based therapies for preventing transplant rejection and graft-versus-host disease.
• To explore the potential of apoptotic donor cells in inducing donor-specific tolerance in solid organ transplantation.
• To highlight limitations, challenges, and advancements in apoptotic cell-based transplant therapies.

Main Methods:

• Review of in vitro and in vivo studies on apoptotic cell clearance and immune tolerance.
• Analysis of laboratory and clinical evidence for apoptotic cell therapy in transplantation.
• Examination of donor antigen presentation by recipient antigen-presenting cells.

Main Results:

• Apoptotic cells aid in maintaining peripheral tolerance to self.
• Donor apoptotic cells can downregulate immune responses and promote donor-specific peripheral tolerance.
• Evidence supports the utility of apoptotic cell-based therapies in managing graft-versus-host disease and transplant rejection.

Conclusions:

• Apoptotic cell-based therapy presents a promising strategy for preventing transplant rejection and graft-versus-host disease.
• This approach may induce donor-specific tolerance in solid organ transplantation, overcoming limitations of current methods.
• Ongoing research aims to address challenges and advance apoptotic donor cell-based therapies for broader clinical application.